Remove 2004 Remove Clinic Remove Spine
article thumbnail

Medicare Part B’s advance beneficiary notice

Chiropractic Economics

Since the ABN form is mandatory only when the otherwise covered service may not be covered that visit, it simply means that it only applies to manual manipulation of the spine when it doesn’t meet Medicare’s definition of medical necessity. Let’s interpret the Act as it relates to chiropractic spinal adjustments.

article thumbnail

Aurora Spine Announces Publication of Biomechanical Study Demonstrating Superiority of SiLO TFX™ Sacroiliac Fusion System

OrthoSpineNews

The study evaluates the biomechanical performance of Aurora Spine’s SiLO TFX MIS Sacroiliac Joint Fixation System compared to traditional posterolateral transosseous techniques. Trent Northcutt, President and CEO of Aurora Spine, expressed satisfaction with the outcomes of the biomechanical study conducted.

Spine 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

5 Effective Cervicogenic Headache Treatments

ChiroUp

Nearly half of the population experiences headaches, and an estimated 25% are cervicogenic headaches, i.e., stemming from dysfunction in the cervical spine. 1,2) While often overlooked, cervicogenic headaches can be just as debilitating as migraines, especially when compounded by cervical spine dysfunction.

Headache 130
article thumbnail

Aurora Spine Announces FDA 510(k) Clearance for the AERO™ Facet Fusion System

OrthoSpineNews

March 25, 2025 (GLOBE NEWSWIRE) — Aurora Spine Corporation (Aurora Spine or the Company) (TSXV: ASG) (OTCQB: ASAPF), a leader in innovative spine and interventional pain management solutions, today announced that the U.S. Like all Aurora products, AERO balances clinical efficacy with procedural simplicity.

Spine 52
article thumbnail

Aurora Spine Corporation Announces Completion of Enrollment in Groundbreaking REFINE Study: First Prospective, Multi-Center, Multi-Specialty Study on Lumbar Interlaminar Fusion 

OrthoSpineNews

This prospective, multi-center, multi-specialty clinical trial is the first of its kind to evaluate the safety and efficacy of lumbar interlaminar fusion devices, marking a significant milestone in the advancement of spinal care. We are incredibly proud to reach this milestone, said Trent Northcutt, President and CEO of Aurora Spine.

article thumbnail

Bone Growth Products Market Size is Expected to Reach USD 1.81 Billion by 2033, Growing at a CAGR of 3.40%: Straits Research

OrthoSpineNews

In clinical contexts, fracture healing is the most prevalent form of bone regeneration, which replicates the path of normal neonatal skeletogenesis, including intramembranous and endochondral ossification. In the United States, elective lumbar fusions rose by approximately 62%, from 122,679 in 2004 to 199,140 in 2015.

Clients 52